Sudeep Pharma Announces Senior Management Personnel Cessation at US Subsidiary
Sudeep Pharma Ltd 路 Change in Management 路 05 Oct 2026, 10:28 pm
Sudeep Pharma Announces Senior Management Personnel Cessation at US Subsidiary Sudeep Pharma Limited has disclosed a change in its Senior Management Personnel following the completion of contractual arrangements with Mr. Sendhil Pani. Mr. Pani, who served as the Managing Director of the company's wholly owned subsidiary, Sudeep Pharma USA Inc., ceased to be designated as Senior Management Personnel effective 2nd Oct'26. Consequently, he is no longer associated with the company in this capacity under Regulation 16(1)(d) of SEBI Listing Regulations.
Original exchange filing (PDF)
More announcements from Sudeep Pharma Ltd
- Submission of Transcript for the Earnings call held on 29.10.2026 路 03 Nov 2026
- Submission of Audio Recording of the Earnings call held on 29th October 2026 路 29 Oct 2026
- Submission of Investors Presentation 路 29 Oct 2026
- Outcome of Board Meeting 路 28 Oct 2026
- Submission of Unaudited Financials Results for the Quarter and half year ended 30th September 2026 路 28 Oct 2026
- Submission of Outcome of Board Meeting 路 28 Oct 2026
- Press Release - FDA Approval for the new pharma greenfield manufacturing facility at 179 Nandesari, Gujarat. 路 26 Oct 2026
- Intimation for the Investor Meet Scheduled to be held on 29th October 2026 at 12:00 noon. 路 29 Oct 2026
